In this comprehensive overview (see Methods and the search methodology in Supplementary Section 1), we aim to identify and describe pre-clinical, mechanistic and clinical studies on the effects of GLP-1RAs in cognitive and mental health disorders, and to provide a summary of available evidence and future perspectives
[16] [4] Those with retinopathy should discuss appropriate monitoring with their healthcare team when starting treatment
Digestive System In your digestive system, GLP-1 medications create multiple effects that support weight loss
Tirzepatide , a dual GIP/GLP-1 receptor agonist, demonstrated superior efficacy to semaglutide in a landmark head-to-head trial, with patients receiving ZEPBOUND losing an average of 50 pounds over 72 weeks compared with 33 pounds among WEGOVY-treated patients
Regular sleep hours and simple stress tools, such as breathing exercises or short movement breaks, help reduce trigger eating
outcomes depend on baseline BMI, diet quality, physical activity, and metabolic response